[Clinical experience with the blood sugar reducing sulfonamide derivative glisoxepide].
D001381:Azepines / Q000009:adverse effects / Q000627:therapeutic use*; D002271:Carbutamide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006029:Glycosuria / Q000139:chemically induced; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007668:Kidney / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010080:Oxazoles / Q000009:adverse effects / Q000627:therapeutic use*; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014044:Tolbutamide / Q000627:therapeutic use
D001381:Azepines; D007004:Hypoglycemic Agents; D010080:Oxazoles; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D002271:Carbutamide
Klinische Erfahrungen mit dem blutzuckersenkenden Sulfonamidderivat Glisoxepid